Over the 90-day window ending February 07, 2026, Contineum Therapeutics's three dominant insider ownership positions are held by Chief Scientific Officer Daniel S. Lorrain (156.05K shares), TenPercentOwner Venture Capital Vi, L.P. Versant (148.31K shares), Cmo & Sr Vp And Clinical Dev. Stephen L. Huhn (12.80K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Daniel S. Lorrain | Chief Scientific Officer | 156,052 | 05 Feb, 2026 |
| Venture Capital Vi, L.P. Versant | 148,312 | 11 Apr, 2024 | |
| Stephen L. Huhn | Cmo & Sr Vp And Clinical Dev. | 12,800 | 14 Aug, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 3,000 | $14.82 | 157,222 | D | S |
| 03 Feb, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 1,170 | $15.25 | 156,052 | D | S |
| 28 Jan, 2026 | Tim Watkins | Class A Common Stock | A | 3,611 | $4.50 | 3,611 | D | M |
| 28 Jan, 2026 | Tim Watkins | Class A Common Stock | D | 811 | $14.48 | 0 | D | S |
| 28 Jan, 2026 | Tim Watkins | Class A Common Stock | D | 2,800 | $14.09 | 811 | D | S |
| 05 Jan, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 500 | $11.13 | 160,222 | D | S |
| 05 Jan, 2026 | Daniel S. Lorrain | Class A Common Stock | D | 3,670 | $10.35 | 160,722 | D | S |
| 29 Dec, 2025 | Tim Watkins | Class A Common Stock | D | 3,611 | $12.06 | 0 | D | S |
| 29 Dec, 2025 | Tim Watkins | Class A Common Stock | A | 3,611 | $4.50 | 3,611 | D | M |
| 23 Dec, 2025 | Daniel S. Lorrain | Class A Common Stock | D | 4,170 | $12.23 | 164,392 | D | S |
| 25 Nov, 2024 | Daniel S. Lorrain | Class A Common Stock | D | 1,010 | $16.02 | 168,562 | D | S |
| 18 Nov, 2024 | Daniel S. Lorrain | Class A Common Stock | D | 6,091 | $16.37 | 169,671 | D | S |
| 18 Nov, 2024 | Daniel S. Lorrain | Class A Common Stock | D | 99 | $17.05 | 169,572 | D | S |
| 13 Aug, 2024 | Stephen L. Huhn | Class A Common Stock | A | 12,800 | $1.01 | 12,800 | D | M |
| 13 Aug, 2024 | Stephen L. Huhn | - | - | 12,800 | D | |||
| 09 Apr, 2024 | Venture Capital Vi, L.P. Versant | - | - | 148,312 | I | |||
| 09 Apr, 2024 | Venture Capital Vi, L.P. Versant | - | - | 391,785 | I | |||
| 09 Apr, 2024 | Venture Capital Vi, L.P. Versant | - | - | 2,531 | I | |||
| 09 Apr, 2024 | Venture Capital Vi, L.P. Versant | Class A Common Stock | A | 391,785 | - | 391,785 | I | C |
| 09 Apr, 2024 | Venture Capital Vi, L.P. Versant | Class A Common Stock | A | 148,312 | - | 148,312 | I | C |